Hydrolytic polysorbate 20 degradation – Sensitive detection of free fatty acids in biopharmaceuticals via UPLC-QDa analytics with isolator column
Dirk-H. Evers(Bio-Rad (Germany)), Julia Buske(Boehringer Ingelheim (Germany)), Dániel Lakatos(Boehringer Ingelheim (Germany)), Frank Hämmerling(Boehringer Ingelheim (Germany)), Patrick Garidel(Boehringer Ingelheim (Germany)), Stefan Carle(Boehringer Ingelheim (Germany))
Journal of Chromatography A
January 1, 2021
Cited by 0
Related Papers
Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates
|Pharmaceutics|2022|93
A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery
|International Journal of Pharmaceutics|2017|55
An in-depth examination of fatty acid solubility limits in biotherapeutic protein formulations containing polysorbate 20 and polysorbate 80
|International Journal of Pharmaceutics|2020|47
The Hsp90 machinery facilitates the transport of diphtheria toxin into human cells
|Scientific Reports|2017|42
Assessing the polysorbate degradation fingerprints and kinetics of lipases – how the activity of polysorbate degrading hydrolases is influenced by the assay and assay conditions
|European Journal of Pharmaceutical Sciences|2021|37